F Mantero Selected Research

aryl hydrocarbon receptor-interacting protein

5/2011	Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up.
12/2010	The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?
9/2010	Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F Mantero Research Topics

Disease

13	Hypertension (High Blood Pressure) 12/2007 - 01/2000
11	Adenoma (Adenomas) 03/2013 - 01/2000
10	Neoplasms (Cancer) 06/2011 - 01/2000
7	Cushing Syndrome 02/2014 - 02/2000
7	Hyperaldosteronism (Conn Syndrome) 03/2012 - 02/2000
5	Pheochromocytoma 06/2011 - 02/2000
5	Insulin Resistance 05/2011 - 06/2000
4	Essential Hypertension 01/2003 - 02/2000
4	Carcinoma (Carcinomatosis) 11/2001 - 01/2000
3	Acromegaly 05/2011 - 07/2008
3	Pituitary Neoplasms (Pituitary Adenoma) 12/2010 - 07/2007
3	Hyperplasia 07/2008 - 02/2003
3	Hypokalemia 03/2007 - 02/2000
3	Obesity 03/2007 - 06/2000
3	Infertility (Sterility) 07/2003 - 09/2001
2	Pituitary ACTH Hypersecretion 04/2014 - 01/2011
2	Adrenocortical Carcinoma 12/2013 - 06/2011
2	Prolactinoma (Prolactinomas) 09/2010 - 07/2007
2	Amenorrhea 12/2007 - 01/2005
2	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 03/2007 - 02/2003
2	Varicocele 01/2004 - 04/2002
2	Adrenocortical Adenoma (Disease, Conn's) 11/2001 - 01/2000
1	Thrombophilia 02/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2014
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 04/2012
1	Adrenal incidentaloma 06/2011
1	Adrenal Gland Neoplasms (Adrenal Cancer) 05/2011
1	Familial Isolated Pituitary Adenoma 09/2010
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 09/2010
1	Hypopituitarism (Sheehan's Syndrome) 09/2008
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 09/2008
1	Acth-Independent Macronodular Adrenal Hyperplasia 12/2007
1	Hirsutism 12/2007
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 03/2007
1	Brain Neoplasms (Brain Tumor) 06/2006

Drug/Important Bio-Agent (IBA)

11	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2011 - 02/2000
8	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2011 - 02/2000
7	AldosteroneIBA 03/2013 - 02/2000
5	Glucose (Dextrose)FDA LinkGeneric 05/2011 - 06/2000
5	MineralocorticoidsIBA 03/2007 - 08/2000
4	Messenger RNA (mRNA)IBA 06/2011 - 06/2000
4	Insulin-Like Growth Factor I (IGF-1)IBA 05/2011 - 06/2006
4	AndrogensIBA 09/2008 - 10/2000
4	SaltsIBA 11/2000 - 01/2000
3	ReninIBA 03/2012 - 06/2000
3	Hormones (Hormone)IBA 06/2011 - 09/2000
3	methylamphotericin B (AME)IBA 06/2011 - 08/2000
3	aryl hydrocarbon receptor-interacting proteinIBA 05/2011 - 09/2010
3	Insulin (Novolin)FDA Link 05/2011 - 01/2005
3	GlucocorticoidsIBA 01/2011 - 02/2003
3	Cortisone FDA Link 12/2003 - 11/2000
3	11-beta-Hydroxysteroid Dehydrogenases (11beta Hydroxysteroid Dehydrogenase)IBA 01/2001 - 08/2000
2	Mitotane (Lysodren)FDA Link 12/2013 - 01/2009
2	Dexamethasone (Maxidex)FDA LinkGeneric 06/2011 - 02/2000
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2011 - 03/2009
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2011 - 12/2007
2	DNA (Deoxyribonucleic Acid)IBA 09/2010 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 01/2009 - 01/2000
2	Estrogens (Estrogen)FDA Link 03/2007 - 04/2001
2	LipidsIBA 01/2006 - 01/2005
2	Triglycerides (Triacylglycerol)IBA 01/2006 - 01/2005
2	Spironolactone (Aldactone)FDA LinkGeneric 01/2005 - 02/2000
2	laurdanIBA 07/2003 - 09/2001
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2001 - 01/2000
2	IsoenzymesIBA 11/2000 - 08/2000
2	AngiotensinogenIBA 06/2000 - 06/2000
1	Cabergoline FDA LinkGeneric 04/2014
1	Ketoconazole (Nizoral)FDA LinkGeneric 04/2014
1	Thrombin FDA Link 02/2014
1	AnticoagulantsIBA 02/2014
1	SeleniumIBA 04/2012
1	gastric inhibitory polypeptide receptorIBA 07/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2011
1	pasireotideIBA 06/2011
1	somatostatin receptor type 1IBA 06/2011
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2011
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 03/2011
1	ProlactinIBA 09/2010
1	lanreotide (Somatuline)FDA Link 03/2009
1	Cisplatin (Platino)FDA LinkGeneric 01/2009
1	AntibodiesIBA 01/2009
1	Tyrosine Kinase InhibitorsIBA 01/2009
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2009
1	Etoposide (VP 16)FDA LinkGeneric 01/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2009
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2009
1	Streptozocin (Streptozotocin)FDA Link 01/2009
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2009
1	LH Receptors (LH Receptor)IBA 12/2007
1	PPAR gammaIBA 07/2007
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2007
1	LigandsIBA 07/2007
1	ThiazolidinedionesIBA 07/2007
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2007
1	Arginine (L-Arginine)FDA Link 06/2006

Therapy/Procedure

8	Therapeutics 04/2014 - 02/2000
7	Adrenalectomy 06/2011 - 02/2000
1	Injections 03/2009
1	Drug Therapy (Chemotherapy) 01/2009
1	Estrogen Replacement Therapy 09/2008